INC

JHP Pharmaceuticals acquired By Warburg Pincus

Wednesday, January 2, 2013 02:28 PM

JHP Pharmaceuticals, a Parsippany, N.J.-based specialty pharmaceutical focused on sterile injectable products, has been acquired by an affiliate of Warburg Pincus, a leading global private equity firm focused on growth investing, for $195 million on a debt-free, cash-free basis. JHP's current management team will continue to hold an interest in the company. Additional terms of the transaction were not disclosed.

More... »

ZeinCRO expands to 14 CSEE countries total

Tuesday, December 18, 2012 11:35 AM

ZeinCRO, a CRO based in Europe, has reinforced its position in Central- and South- Eastern Europe (CSEE), with the opening of offices in 5 additional countries, extending its reach to 14 countries in total.

More... »

The Medicines Company to acquire Incline Therapeutics

Friday, December 14, 2012 10:14 AM

The Medicines Company, a medical solutions company based in Parsippany, N.J., has agreed to acquire Incline Therapeutics, hospital-focused specialty pharmaceutical company based in Redwood City, Calif.

More... »

INC Research strengthens leadership for strategic advisory services unit

Monday, December 10, 2012 01:44 PM

INC Research, a therapeutically focused CRO, has appointed Robert Ryan, PhD, as vice president of regulatory strategy, consulting and submissions. Ryan will provide global leadership to position INC Strategic Advisory Services as a market leader in regulatory consulting and submissions offerings.

More... »

INC Research launches strategic advisory services unit

Wednesday, December 5, 2012 12:02 PM

INC Research, a therapeutically focused CRO, has launched INC Research Strategic Advisory Services, a new global business unit dedicated to providing biopharmaceutical customers with world-class consulting capabilities in the areas of drug development and commercialization, regulatory consulting and submissions and quality assurance.

More... »

Principia Biopharma secures $12.5M second tranche in Series A financing

Tuesday, October 30, 2012 10:51 AM

Principia Biopharma, a South San Francisco-based privately held biopharmaceutical company focused on advancing best-in-class medicines in immunology, autoimmune diseases, and oncology, has successfully met its milestone obligations and received its second tranche of funding totaling $12.5 million.

More... »

Roche, Versant, Inception pursue novel treatments for sensorineural hearing loss

Wednesday, October 10, 2012 02:03 PM

Roche has entered into an exclusive partnership with Versant Ventures,  healthcare venture capital firm based in Menlo Park, Calif., and Inception Sciences, a San Diego-based drug discovery company, to create a drug discovery incubator, Inception 3, for the treatment of sensorineural hearing loss.

More... »

Nextrials, InClin partner to provide next gen clinical research services

Wednesday, October 10, 2012 10:38 AM

Nextrials, a clinical research software and services company based in San Ramon, Calif., has formed a partnership with InClin, a specialized CRO of Los Altos, Calif., to provide next generation clinical research services.

More... »

Vince & Assoc. awarded $5M FDA contract to conduct clinical studies

Wednesday, September 26, 2012 10:21 AM

Vince & Associates Clinical Research, a clinical research services company based in Overland Park, Kan., has been awarded a contract with the FDA’s Center for Drug Evaluation and Research (CDER) to conduct bioequivalence studies of innovator and generic drugs such as anti-epileptic drugs.

More... »

Mallinckrodt to acquire CNS Therapeutics

Tuesday, September 25, 2012 10:31 AM

Mallinckrodt, the pharmaceuticals business of Covidien, a global healthcare products company, has agreed to acquire CNS Therapeutics, a St. Paul, Minn.-based specialty pharmaceutical company focused on neurological disorders and intractable chronic pain.

More... »